DXCM Relative Valuation
DXCM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, DXCM is overvalued; if below, it's undervalued.
Historical Valuation
Dexcom Inc (DXCM) is now in the Undervalued zone, suggesting that its current forward PE ratio of 24.38 is considered Undervalued compared with the five-year average of 91.50. The fair price of Dexcom Inc (DXCM) is between 102.42 to 283.34 according to relative valuation methord. Compared to the current price of 58.49 USD , Dexcom Inc is Undervalued By 42.89%.
Relative Value
Fair Zone
102.42-283.34
Current Price：58.49
42.89%
Undervalued
24.56
PE
1Y
3Y
5Y
Trailing
Forward
13.76
EV/EBITDA
Dexcom Inc. (DXCM) has a current EV/EBITDA of 13.76. The 5-year average EV/EBITDA is 48.29. The thresholds are as follows: Strongly Undervalued below -2.17, Undervalued between -2.17 and 23.06, Fairly Valued between 73.53 and 23.06, Overvalued between 73.53 and 98.76, and Strongly Overvalued above 98.76. The current Forward EV/EBITDA of 13.76 falls within the Undervalued range.
19.48
EV/EBIT
Dexcom Inc. (DXCM) has a current EV/EBIT of 19.48. The 5-year average EV/EBIT is 67.77. The thresholds are as follows: Strongly Undervalued below 4.72, Undervalued between 4.72 and 36.25, Fairly Valued between 99.29 and 36.25, Overvalued between 99.29 and 130.81, and Strongly Overvalued above 130.81. The current Forward EV/EBIT of 19.48 falls within the Undervalued range.
58.49
PS
Dexcom Inc. (DXCM) has a current PS of 58.49. The 5-year average PS is 12.29. The thresholds are as follows: Strongly Undervalued below -1.00, Undervalued between -1.00 and 5.64, Fairly Valued between 18.94 and 5.64, Overvalued between 18.94 and 25.59, and Strongly Overvalued above 25.59. The current Forward PS of 58.49 falls within the Strongly Overvalued range.
17.82
P/OCF
Dexcom Inc. (DXCM) has a current P/OCF of 17.82. The 5-year average P/OCF is 56.15. The thresholds are as follows: Strongly Undervalued below 6.65, Undervalued between 6.65 and 31.40, Fairly Valued between 80.90 and 31.40, Overvalued between 80.90 and 105.65, and Strongly Overvalued above 105.65. The current Forward P/OCF of 17.82 falls within the Undervalued range.
24.72
P/FCF
Dexcom Inc. (DXCM) has a current P/FCF of 24.72. The 5-year average P/FCF is 100.02. The thresholds are as follows: Strongly Undervalued below -33.64, Undervalued between -33.64 and 33.19, Fairly Valued between 166.85 and 33.19, Overvalued between 166.85 and 233.68, and Strongly Overvalued above 233.68. The current Forward P/FCF of 24.72 falls within the Undervalued range.
Dexcom Inc (DXCM) has a current Price-to-Book (P/B) ratio of 8.31. Compared to its 3-year average P/B ratio of 17.54 , the current P/B ratio is approximately -52.65% higher. Relative to its 5-year average P/B ratio of 18.74, the current P/B ratio is about -55.67% higher. Dexcom Inc (DXCM) has a Forward Free Cash Flow (FCF) yield of approximately 4.69%. Compared to its 3-year average FCF yield of 1.52%, the current FCF yield is approximately 207.64% lower. Relative to its 5-year average FCF yield of 1.09% , the current FCF yield is about 329.52% lower.
8.37
P/B
Median3y
17.54
Median5y
18.74
0.05
FCF Yield
Median3y
1.52
Median5y
1.09
Competitors Valuation Multiple
The average P/S ratio for DXCM's competitors is 219.65, providing a benchmark for relative valuation. Dexcom Inc Corp (DXCM) exhibits a P/S ratio of 58.49, which is -73.37% above the industry average. Given its robust revenue growth of 21.64%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of DXCM decreased by 25.00% over the past 1 year. The primary factor behind the change was an increase in Margin Expansion from 13.54 to 23.47.
The secondary factor is the Revenue Growth, contributed 21.64%to the performance.
Overall, the performance of DXCM in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
FAQ
Is Dexcom Inc (DXCM) currently overvalued or undervalued?
What is Dexcom Inc (DXCM) fair value?
How does DXCM's valuation metrics compare to the industry average?
What is the current P/B ratio for Dexcom Inc (DXCM) as of Nov 19 2025?
What is the current FCF Yield for Dexcom Inc (DXCM) as of Nov 19 2025?
What is the current Forward P/E ratio for Dexcom Inc (DXCM) as of Nov 19 2025?